enVVeno Medical Corporati... (NVNO)
| Bid | 2.35 |
| Market Cap | 42.96M |
| Revenue (ttm) | 812K |
| Net Income (ttm) | -21.82M |
| EPS (ttm) | -1.27 |
| PE Ratio (ttm) | -1.93 |
| Forward PE | -2.89 |
| Analyst | n/a |
| Ask | 2.74 |
| Volume | 22,602 |
| Avg. Volume (20D) | 96,367 |
| Open | 2.40 |
| Previous Close | 2.38 |
| Day's Range | 2.31 - 2.45 |
| 52-Week Range | 2.03 - 6.48 |
| Beta | 1.04 |
About NVNO
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blo...
2 days ago · accessnewswire.com
enVVeno Medical to Participate in a Live Virtual Investor Closing Bell SegmentModerated webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Tuesday, April 22nd at 4:00 PM ET IRVINE, CA / ACCESS Newswire / April 16, 2025 / enVVeno Medical Corporation (Nasda...
1 month ago · accessnewswire.com
enVVeno Medical Participates in the Virtual Investor “Top 5 for ‘25” On-Demand ConferenceOn-demand video webcast now available here IRVINE, CA / ACCESS Newswire / February 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of...
